Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease.
CONCLUSION: Exenatide plus insulin glargine treatment for 24 weeks resulted in a reduction of albuminuria in T2DM patients with DKD.
PMID: 32966971 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Wang X, Zhang H, Zhang Q, Guan M, Sheng S, Mo W, Zou M, Li J, Bi J, Tang X, Zeng H, He J, Xu G, Li P, Xue Y Tags: Am J Nephrol Source Type: research
More News: Byetta | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gastroenterology | Heart | Humalog | Insulin | Lantus | Study | Urology & Nephrology